» Articles » PMID: 16501070

Epitope Mapping of Herpes Simplex Virus Type 2 GH/gL Defines Distinct Antigenic Sites, Including Some Associated with Biological Function

Overview
Journal J Virol
Date 2006 Feb 28
PMID 16501070
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

The gH/gL complex plays an essential role in virus entry and cell-cell spread of herpes simplex virus (HSV). Very few immunologic reagents were previously available to either identify important functional regions or gain information about structural features of this complex. Therefore, we generated and characterized a panel of 31 monoclonal antibodies (MAbs) against HSV type 2 (HSV-2) gH/gL. Fourteen MAbs bound to a conformation-dependent epitope of the gH2/gL2 complex, and all blocked virus spread. The other 17 MAbs recognized linear epitopes of gH (12) or gL (5). Interestingly, two of the gL MAbs and six of the gH MAbs were type common. Overlapping synthetic peptides were used to map MAbs against linear epitopes. These data, along with results of competition analyses and functional assays, assigned the MAbs to groups representing eight distinct antigenic sites on gH (I to VIII) and three sites on gL (A, B, and C). Of most importance, the MAbs with biological activity mapped either to site I of gH2 (amino acids 19 to 38) or to sites B and C of gL2 (residues 191 to 210). Thus, these MAbs constitute a novel set of reagents, including the first such reagents against gH2 and gL2 as well as some that recognize both serotypes of each protein. Several recognize important functional domains of gH2, gL2, or the complex. We suggest a common grouping scheme for all of the known MAbs against gH/gL of both HSV-1 and HSV-2.

Citing Articles

Targeting Herpes Simplex Virus Glycoprotein D with Bispecific Antibodies: Expanding Therapeutic Horizons by Searching for Synergy.

Atanasiu D, Saw W, Friedman H, Cohen G Viruses. 2025; 17(2).

PMID: 40007004 PMC: 11860751. DOI: 10.3390/v17020249.


Well Put Together-A Guide to Accessorizing with the Herpesvirus gH/gL Complexes.

Gonzalez-Del Pino G, Heldwein E Viruses. 2022; 14(2).

PMID: 35215889 PMC: 8874593. DOI: 10.3390/v14020296.


Herpes Simplex Virus Cell Entry Mechanisms: An Update.

Madavaraju K, Koganti R, Volety I, Yadavalli T, Shukla D Front Cell Infect Microbiol. 2021; 10:617578.

PMID: 33537244 PMC: 7848091. DOI: 10.3389/fcimb.2020.617578.


Using Split Luciferase Assay and anti-HSV Glycoprotein Monoclonal Antibodies to Predict a Functional Binding Site Between gD and gH/gL.

Atanasiu D, Saw W, Cairns T, Eisenberg R, Cohen G J Virol. 2021; 95(8).

PMID: 33504603 PMC: 8103690. DOI: 10.1128/JVI.00053-21.


Conformation-selective tau monoclonal antibodies inhibit tau pathology in primary neurons and a mouse model of Alzheimer's disease.

Gibbons G, Kim S, Wu Q, Riddle D, Leight S, Changolkar L Mol Neurodegener. 2020; 15(1):64.

PMID: 33148293 PMC: 7643305. DOI: 10.1186/s13024-020-00404-5.


References
1.
Buckmaster E, Gompels U, Minson A . Characterisation and physical mapping of an HSV-1 glycoprotein of approximately 115 X 10(3) molecular weight. Virology. 1984; 139(2):408-13. DOI: 10.1016/0042-6822(84)90387-8. View

2.
Dubin G, Jiang H . Expression of herpes simplex virus type 1 glycoprotein L (gL) in transfected mammalian cells: evidence that gL is not independently anchored to cell membranes. J Virol. 1995; 69(7):4564-8. PMC: 189206. DOI: 10.1128/JVI.69.7.4564-4568.1995. View

3.
Evan G, LEWIS G, Ramsay G, Bishop J . Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product. Mol Cell Biol. 1985; 5(12):3610-6. PMC: 369192. DOI: 10.1128/mcb.5.12.3610-3616.1985. View

4.
Miller N, Hutt-Fletcher L . A monoclonal antibody to glycoprotein gp85 inhibits fusion but not attachment of Epstein-Barr virus. J Virol. 1988; 62(7):2366-72. PMC: 253393. DOI: 10.1128/JVI.62.7.2366-2372.1988. View

5.
Isola V, Eisenberg R, Siebert G, Heilman C, Wilcox W, Cohen G . Fine mapping of antigenic site II of herpes simplex virus glycoprotein D. J Virol. 1989; 63(5):2325-34. PMC: 250651. DOI: 10.1128/JVI.63.5.2325-2334.1989. View